Electrophysiology Mapping and Ablation Devices – Market Insights – Europe

The European EP mapping and ablation device market will experience moderate growth through 2032 due to increasing ablation procedure volumes, technological advancements, and the uptake of premium-priced devices.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in Europe from 2019 to 2032.

Expansion of the European EP mapping and ablation device market will be driven by increasing procedure volumes, particularly in the AF indication.

How fast are AF treatment volumes growing, and how different is the growth rate from other arrhythmia types?

How will shifting physician opinions on ablation techniques for treating AF affect device use?

Technological advancements in cryoablation and PFA are increasingly gaining acceptance in the European market.

How is PFA advantageous over other ablation techniques?

How recent clinical trial results are impacting the EP ablation catheter market?

Which new products have been approved and are expected to be approved in the market?

What are the changing catheter preferences among electrophysiologists?

Several new technologies are being introduced commercially, with more undergoing clinical trials.

What technologies will enter the market going forward, and when are they expected to be launched?

How will the uptake of new devices affect pricing trends and revenue growth?

Which new competitors could enter the market? How is their technology differentiated from what is available today?

The reimbursement landscape for EP mapping and ablation devices differs between European countries.

How will this affect the adoption of advanced devices that command a premium price?

What strategies can companies adapt to address the increasing cost consciousness among healthcare facilities?

The reprocessing of EP catheters continues to affect the EP catheter market.

To what extent are institutions turning to reprocessed diagnostic and ablation catheters to lower costs?

Which catheters are reprocessed, and how does device reprocessing affect market revenues?

What are the regulations in different countries for reprocessing of diagnostic and ablation catheters?

The COVID-19 pandemic had a significant impact on EP ablation procedures.

What is the recovery outlook for 2022 and going forward?

What factors are driving the recovery of procedures in this market?

Table of contents

Electrophysiology Mapping and Ablation Devices - Market Insights - Europe

Pankhil Gandhi, PharmD

Pankhil Gandhi is an analyst within the Cardiovascular Medtech Insights team at Clarivate, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.

Contact sales Login to access report

Back to all Medtech Insights reports